Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biomarkers for biological agents

N Muñoz1, F X Bosch

  • 1Unit of Field and Intervention Studies, International Agency for Research on Cancer, Lyon, France.

IARC Scientific Publications
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2: A multicenter prospective study.

Medicina intensiva·2022
Same author

Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2: A multicenter prospective study.

Medicina intensiva·2021
Same author

Reply letter re: "Mass psychogenic illness following HPV immunization in Carmen de Bolivar, Colombia".

Human vaccines & immunotherapeutics·2019
Same author

Preoperative factors associated with technical difficulties of laparoscopic cholecystectomy in acute cholecystitis.

Radiologia·2017
Same author

[Human papillomavirus nonavalent vaccine. Update 2017].

Semergen·2017
Same author

Differential HPV16 variant distribution in squamous cell carcinoma, adenocarcinoma and adenosquamous cell carcinoma.

International journal of cancer·2017
Same journal

North America.

IARC scientific publications·2016
Same journal

Central and South America.

IARC scientific publications·2016
Same journal

Africa.

IARC scientific publications·2016
Same journal

Data availability and presentation.

IARC scientific publications·2016
Same journal

Age standardization.

IARC scientific publications·2016
Same journal

Data processing.

IARC scientific publications·2016
See all related articles

Biomarkers for human papillomavirus (HPV), hepatitis B (HBV), hepatitis C virus (HCV), and Helicobacter pylori are crucial for cancer research. These biological agent exposure markers aid in understanding infection-cancer links and disease progression.

Area of Science:

  • Oncology
  • Infectious Diseases
  • Epidemiology

Background:

  • Biological agent exposure biomarkers are vital for establishing causal links between infections and human cancers.
  • The International Agency for Research on Cancer (IARC) has recognized specific agents causally associated with various human cancers.

Purpose of the Study:

  • To review biomarkers for biological agents causally linked to human cancers, including HPV, HBV, HCV, and H. pylori.
  • To discuss the utility and limitations of these biomarkers in epidemiological investigations and cancer research.

Main Methods:

  • Focus on nucleic acid-based biomarkers, such as HPV DNA detection using PCR assays.
  • Review of serological biomarkers for HBV and HCV, including antigen and antibody detection.
  • Discussion of emerging methods like HBV DNA and HCV RNA detection.

Related Experiment Videos

Main Results:

  • HPV DNA detection via PCR is a preferred method for epidemiological studies, with stable specimen storage.
  • HBV markers can differentiate past from persistent infections, and HBV DNA aids exposure assessment.
  • Standardized serological assays for HBV and HCV are available, though HCV subtype variation presents challenges.

Conclusions:

  • Biomarkers for HPV, HBV, HCV, and H. pylori are essential tools in cancer research and epidemiology.
  • Ongoing research is needed to address limitations such as HPV DNA transient infections and HCV geographical variations.
  • Improved diagnostic and confirmatory tests are necessary, especially in low-risk populations to minimize false positives.